InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) — Form 8-K: Current report
About this filing
InMed Pharmaceuticals Inc. (INM) filed an 8-K on Nov 3, 2026 reporting a Regulation FD disclosure (Item 7.01), with exhibits (Item 9.01).
Key facts
- Item 7.01 · Regulation FD disclosure
- Item 9.01 · Financial statements and exhibits
More INM filings
- 8-K
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- 10-Q
Filed Nov 2, 2026
- 425
Filed Nov 2, 2026
- 424B3
Filed Oct 28, 2026
- 4
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.